Advertisement
Screener

PHARMACYTE BIOTECH, INC. (PMCB) Shareholder Equity

PHARMACYTE BIOTECH, INC. (PMCB) Shareholder Equity

  • 2026-07-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $2.60K; Additional Paid in CapitalUSD $182.01M; Treasury Stock, Common, ValueUSD $45.01M.
  • 2026-04-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.60K; Additional Paid in CapitalUSD $182.72M; Treasury Stock, Common, ValueUSD $45.01M.
  • 2026-01-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $2.60K; Additional Paid in CapitalUSD $183.14M; Treasury Stock, Common, ValueUSD $45.01M.
  • 2025-10-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $2.17K; Additional Paid in CapitalUSD $180.61M; Treasury Stock, Common, ValueUSD $44.61M.

PHARMACYTE BIOTECH, INC. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Treasury Stock, Common, Value
USD
Accumulated Other Comprehensive Income (Loss), Net of Tax
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
Treasury Stock, Common, Shares
shares
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
USD
Adjustments to Additional Paid in Capital, Other
USD
Treasury Stock, Value
USD
Adjustments to Additional Paid in Capital, Warrant Issued
USD
Treasury Stock, Shares
shares
2026-07-31(m)$2.60K$182.01M$45.01M$-21.41K$-109.47M$27.51M15.27M(m)3 month · $83.40K(m)(m)(m)(m)
2026-04-30$0.00$2.60K$182.72M$45.01M$-20.80K$-104.39M$33.29M15.27M12 month · $236.06K12 month · $278.50K(m)(m)(m)(m)
2026-01-31(m)$2.60K$183.14M$45.01M$-21.54K$-100.00M$38.11M(m)3 month · $60.49K3 month · $98.46K(m)(m)(m)(m)
2025-10-31(m)$2.17K$180.61M$44.61M$-24.13K$-100.75M$35.24M(m)3 month · $60.49K(m)(m)(m)(m)(m)
2025-07-31(m)$2.17K$181.55M$44.61M$-23.75K$-93.33M$43.59M(m)3 month · $60.49K(m)(m)(m)(m)(m)
2025-04-30$0.00$2.17K$181.49M$44.61M$-23.87K$-84.97M$51.89M14.88M12 month · $478.64K12 month · $227.18K(m)(m)(m)(m)
2025-01-31$0.00$2.17K$181.43M$44.43M$-24.49K$-96.72M$40.25M14.77M3 month · $72.86K(m)(m)(m)(m)(m)
2024-10-31$0.00$2.17K$181.35M$44.21M$-23.27K$-93.67M$43.45M14.64M3 month · $119.16K3 month · $443.96K(m)(m)(m)(m)
2024-07-31$0.00$2.17K$182.72M$42.79M$-23.33K$-92.20M$47.71M13.95M3 month · $222.68K3 month · $685.80K(m)(m)(m)(m)
2024-04-30$0.00$2.17K$185.33M$42.04M$-23.51K$-115.63M$27.65M13.63M12 month · $674.69K(m)(m)(m)(m)(m)
2024-01-31$0.00$2.17K$189.22M$40.85M$-23.07K$-116.97M$31.37M13.15M3 month · $674.69K(m)(m)(m)(m)(m)
2023-10-31$0.00$2.17K$193.59M$40.45M$-24.14K$-116.35M$36.77M12.97M(m)(m)(m)(m)(m)(m)
2023-07-31$20.03M$2.17K$198.64M$40.02M$-22.55K$-119.14M$39.19M12.89M(m)3 month · $319.85K3 month · $-319.85K$40.28M(m)(m)
2023-05-11(m)(m)(m)(m)(m)(m)(m)8.09M(m)(m)(m)(m)(m)(m)
2023-04-30$0.00$2.16K$202.23M$13.56M$-23.00K$-115.96M$72.69M4.81M12 month · $638.07K(m)(m)(m)(m)(m)
2023-01-31(m)$2.16K$202.23M(m)$-17.73K$-115.84M$77.12M(m)3 month · $629.26K(m)(m)$9.25M(m)3.39M
2022-10-31(m)$2.16K$201.60M(m)$-15.17K$-115.07M$81.04M(m)3 month · $4.21K(m)(m)$5.48M(m)2.08M
2022-07-31(m)$2.16K$201.59M(m)$-14.45K$-113.19M$86.30M(m)3 month · $4.59K(m)(m)$2.09M(m)851.98K
2022-04-30(m)$2.07K$201.58M$0.00$-15.76K$-111.65M$89.92M0.0012 month · $44.81K(m)(m)$0.0012 month · $4.75M(m)
2022-01-31(m)$2.07K$201.57M(m)$-19.30K$-110.23M$91.33M(m)3 month · $7.37K(m)(m)(m)(m)(m)
2021-10-31(m)$2.07K$201.56M(m)$-19.09K$-109.41M$92.12M(m)3 month · $10.38K(m)(m)(m)3 month · $4.75M(m)
2021-07-31(m)$161.00$114.17M(m)$-22.00K$-108.43M$5.71M(m)3 month · $24.14K(m)(m)(m)(m)(m)
2021-04-30(m)$159.00$114.11M(m)$-20.38K$-107.41M$6.68M(m)12 month · $176.57K(m)(m)(m)(m)(m)
2021-01-31(m)$234.14K$113.85M(m)$-21.02K$-106.45M$7.61M(m)3 month · $38.61K(m)(m)(m)(m)(m)
2020-10-31(m)$233.48K$113.76M(m)$-21.88K$-105.69M$8.28M(m)3 month · $56.06K(m)(m)(m)(m)(m)
2020-07-31(m)$187.51K$110.82M(m)$-19.03K$-104.74M$6.25M(m)3 month · $72.32K(m)(m)(m)(m)(m)
2020-04-30(m)$109.00$108.97M(m)$-21.71K$-103.86M$5.09M(m)12 month · $379.38K(m)(m)(m)(m)(m)
2020-01-31$0.00$142.85K$107.31M(m)$-21.37K$-103.11M$4.32M(m)3 month · $84.44K(m)(m)(m)(m)(m)
2019-10-31(m)$133.19K$106.65M(m)$-20.77K$-102.23M$4.53M(m)3 month · $98.41K(m)(m)(m)(m)(m)
2019-07-31(m)$125.82K$106.06M(m)$-20.70K$-101.17M$5.00M(m)3 month · $126.33K(m)(m)(m)(m)(m)
2019-04-30$0.00$118.60K$104.97M(m)$-13.84K$-100.03M$5.04M(m)12 month · $412.35K(m)(m)(m)(m)(m)
2019-01-31(m)$112.69K$104.15M(m)$-8.50K$-98.89M$5.37M(m)3 month · $72.48K(m)(m)(m)(m)(m)
2018-10-31(m)$108.14K$103.52M(m)$-12.04K$-98.22M$5.40M(m)3 month · $96.96K(m)(m)(m)(m)(m)
2018-07-31(m)$107.95K$103.28M(m)$-5.98K$-97.18M$6.20M(m)3 month · $113.22K(m)(m)(m)(m)(m)
2018-04-30(m)$101.33K$101.64M(m)$-4.71K$-95.96M$5.77M(m)12 month · $945.08K(m)(m)(m)(m)(m)
2018-01-31(m)$98.03K$100.41M(m)$-1.24K$-94.67M$5.84M(m)3 month · $306.91K(m)(m)(m)(m)(m)
2017-10-31(m)$97.37K$99.89M(m)$265.00$-92.64M$7.35M(m)3 month · $245.09K(m)(m)(m)(m)(m)
2017-07-31(m)$97.32K$99.39M(m)$18.00$-90.82M$8.66M(m)3 month · $244.70K(m)(m)(m)(m)(m)
2017-04-30(m)$90.53K$97.13M(m)$1.74K$-89.14M$8.09M(m)12 month · $597.40K(m)(m)(m)(m)(m)
2017-01-31(m)$87.22K$94.93M(m)$1.94K$-87.98M$7.04M(m)(m)(m)(m)(m)(m)(m)
2016-10-31(m)$84.92K$92.89M(m)$1.64K$-86.70M$6.28M(m)(m)(m)(m)(m)(m)(m)
2016-07-31(m)$84.87K$92.70M(m)$1.25K$-85.72M$7.07M(m)(m)(m)(m)(m)(m)(m)
2016-04-30(m)$78.13K$91.14M(m)$806.00$-84.69M$6.52M(m)12 month · $788.77K(m)(m)(m)(m)(m)
2016-01-31$0.00$77.14K$90.43M(m)$1.79K$-83.57M$6.94M(m)(m)(m)(m)(m)(m)(m)
2015-10-31$0.00$74.75K$88.60M(m)$1.59K$-81.78M$6.90M(m)(m)(m)(m)(m)(m)(m)
2015-07-31$0.00$74.26K$87.90M(m)$1.62K$-80.14M$7.83M(m)(m)(m)(m)(m)(m)(m)
2015-04-30$0.00$73.27K$86.33M(m)$1.46K$-78.63M$7.78M(m)12 month · $5.24M(m)(m)(m)12 month · $1.15M(m)
2015-01-31$0.00$70.34K$83.24M(m)(m)$-77.07M$6.25M(m)(m)(m)(m)(m)(m)(m)
2014-10-31$0.00$69.61K$81.92M(m)(m)$-75.61M$6.38M(m)(m)(m)(m)(m)(m)(m)
2014-07-31$0.00$71.04K$78.04M(m)(m)$-70.28M$7.83M(m)(m)(m)(m)(m)(m)(m)
2014-04-30$0.00$69.06K$76.00M(m)$0.00$-68.70M$8.94M(m)(m)(m)(m)(m)(m)(m)
2014-01-31$0.00$60.30K$55.40M(m)(m)$-52.23M$5.18M(m)(m)(m)(m)(m)(m)(m)
2013-10-31$0.00$58.84K$53.82M(m)(m)$-51.77M$3.60M(m)(m)(m)(m)(m)(m)100.00M
2013-07-31$500.00K$53.70K$47.86M(m)(m)$-46.11M$1.90M(m)(m)(m)(m)(m)(m)(m)
2013-04-30$580.00K$48.21K$39.90M(m)(m)$-41.45M$-1.50M(m)(m)(m)(m)(m)(m)(m)
2013-01-31$580.00K$45.79K$39.04M(m)(m)$-41.12M$-2.03M(m)(m)(m)(m)(m)(m)(m)
2012-10-31$580.00K$44.45K$38.64M(m)(m)$-40.74M$-2.05M(m)(m)(m)(m)(m)(m)(m)
2012-07-31$580.00K$42.34K$37.94M(m)(m)$-40.36M$-2.37M(m)(m)(m)(m)(m)(m)(m)
2012-04-30$580.00K$41.63K$37.53M(m)(m)$-39.85M$-2.28M(m)(m)(m)(m)(m)(m)(m)
2012-01-31(m)$37.44K$35.46M(m)(m)$-39.34M$-2.25M(m)(m)(m)(m)(m)(m)(m)
2011-10-31(m)$37.43K$35.46M(m)(m)$-39.07M$-2.38M(m)(m)(m)(m)(m)(m)(m)
2011-07-31(m)$37.33K$35.40M(m)(m)$-38.63M$-2.41M(m)(m)(m)(m)(m)(m)(m)
2011-04-30(m)$35.71K$34.42M(m)(m)$-37.95M$-2.73M(m)(m)(m)(m)(m)(m)(m)
2011-03-01$80.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-04-30(m)(m)(m)(m)(m)(m)$-2.45M(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70